- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Pulmonary Aspergillosis in United Kingdom
Total 3014 results
-
St George's University Hospitals NHS Foundation...University College, London; St George's, University of London; University of... and other collaboratorsRecruitingInvasive Pulmonary Aspergillosis | Invasive Fungal DiseaseUnited Kingdom
-
Zambon SpACompletedAllergic Bronchopulmonary AspergillosisUnited Kingdom
-
Community Pharmacology Services LtdPulmatrix Inc.WithdrawnAsthma | Allergic Bronchopulmonary Aspergillosis | ABPAUnited Kingdom
-
Arkansas Children's Hospital Research InstituteNational Institute of Allergy and Infectious Diseases (NIAID); Children's Hospital...RecruitingPulmonary Invasive Fungal Infections | Pulmonary Invasive AspergillosisUnited States, Canada
-
National Cancer Institute (NCI)CompletedInvasive Pulmonary Aspergillosis | Immunocompromised Host | Invasive Pulmonary Fungal Infection | Invasive Pulmonary ZygomycosisUnited States
-
F2G Biotech GmbHQuotient ClinicalCompleted
-
F2G Biotech GmbHHammersmith Medicines ResearchCompletedInvasive AspergillosisUnited Kingdom
-
Pulmocide LtdRecruitingRefractory IPASpain, United States, Canada, Italy, Austria, France, Israel, United Kingdom, Belgium, Korea, Republic of, Brazil, Germany, Chile, Greece, Taiwan, Argentina, Colombia
-
Pulmatrix Inc.TerminatedAllergic Bronchopulmonary AspergillosisUnited States, Australia, United Kingdom, India, Poland
-
Novartis PharmaceuticalsTerminatedCystic Fibrosis | Allergic Bronchopulmonary AspergillosisUnited Kingdom, Germany, Belgium, Italy, Netherlands
-
Scynexis, Inc.CompletedInvasive Pulmonary AspergillosisUnited States, Belgium, Canada, Germany, South Africa
-
F2G Biotech GmbHQuotient ClinicalWithdrawn
-
F2G Biotech GmbHHammersmith Medicines ResearchCompleted
-
VicalTerminatedInvasive Aspergillosis | Invasive Pulmonary AspergillosisUnited States, Korea, Republic of, Canada, Belgium, France, Germany
-
F2G Biotech GmbHCelerion LtdCompletedInvasive AspergillosisUnited Kingdom
-
F2G Biotech GmbHSimbec-Orion GroupCompleted
-
Regeneron PharmaceuticalsSanofiCompletedAllergic Bronchopulmonary AspergillosisUnited States, Hungary, Bulgaria, France, Germany, Japan, Netherlands, Poland, Romania, United Kingdom
-
F2G Biotech GmbHCovanceCompletedInvasive AspergillosisUnited Kingdom
-
F2G Biotech GmbHSimbecRresearch Ltd.CompletedInvasive AspergillosisUnited Kingdom
-
F2G Biotech GmbHSimbec ResearchCompletedInvasive AspergillosisUnited Kingdom
-
Baylor Research InstituteWithdrawnSevere Asthma | Allergic Bronchopulmonary Aspergillosis | ABPAUnited States
-
Pulmatrix Inc.TerminatedABPAAustralia, United States, United Kingdom, France
-
King's College Hospital NHS TrustCompletedNeutropenia | Invasive AspergillosisUnited Kingdom
-
European Organisation for Research and Treatment...CompletedInfection | Pulmonary ComplicationsFrance, Spain, Switzerland, Australia, Sweden, Luxembourg, Belgium, Germany, United Kingdom, Hungary, Italy, Israel, Ireland, Netherlands, United States
-
Scynexis, Inc.CompletedCoccidioidomycosis | Invasive Pulmonary Aspergillosis | Allergic Bronchopulmonary Aspergillosis | Histoplasmosis | Chronic Pulmonary Aspergillosis | Blastomycosis | Invasive Candidiasis | Recurrent Vulvovaginal Candidiasis | Mucocutaneous Candidiasis | Other Emerging FungiUnited States, Spain, United Kingdom, Austria, Pakistan, South Africa, Germany, Netherlands
-
Pulmocide LtdCompletedPulmonary AspergillosisUnited States, Canada
-
University of PittsburghNational Heart, Lung, and Blood Institute (NHLBI)CompletedCystic Fibrosis | Allergic Bronchopulmonary AspergillosisUnited States
-
University of PittsburghNational Heart, Lung, and Blood Institute (NHLBI)CompletedCystic Fibrosis | Allergic Bronchopulmonary AspergillosisUnited States
-
PfizerCompletedMucormycosis | Invasive AspergillosisSpain, Germany, France, United Kingdom, Italy
-
Sheffield Teaching Hospitals NHS Foundation TrustWithdrawn
-
Brynn ChappellThe Christie NHS Foundation TrustSuspendedAspergillosis | Immunocompromised Patient | FusariumUnited Kingdom
-
University of Alabama at BirminghamUniversity of Colorado, DenverCompletedFungal Infection | Cystic Fibrosis | Allergic Bronchopulmonary AspergillosisUnited States
-
Jeffrey Jenks, MD, MPHAstellas Pharma Global Development, Inc.TerminatedSevere Acute Respiratory Syndrome Coronavirus 2 | Aspergillosis InvasiveUnited States
-
Pulmocide LtdTerminatedBronchiectasis | Asthma | COPD | Respiratory Candidiasis | Respiratory AspergillosisUnited Kingdom
-
Astellas Pharma IncWithdrawnAspergillosis/Blood | Aspergillosis/InvasiveUnited States
-
Pulmocide LtdCompletedAspergillosisUnited Kingdom
-
F2G Biotech GmbHIqvia Pty Ltd; ShionogiRecruitingInvasive AspergillosisUnited States, Taiwan, Belgium, Spain, Italy, Turkey, New Zealand, China, Canada, Netherlands, Australia, Brazil, Singapore, Israel, France, Thailand, Germany, Japan, Korea, Republic of, United Kingdom
-
Pulmocide LtdTerminatedAspergillosis | Lung Transplant InfectionUnited Kingdom
-
PfizerTerminatedInvasive AspergillosisSpain, United States, Singapore, Canada, Czechia, Netherlands, Poland, Thailand
-
Merck Sharp & Dohme LLCCompletedInvasive AspergillosisBelgium, United States, Greece, Hungary, Israel, Italy, Korea, Republic of, Mexico, Peru, Russian Federation
-
King's College Hospital NHS TrustUniversity of BrightonCompletedChronic Obstructive Pulmonary Disease (COPD)United Kingdom
-
Papworth Hospital NHS Foundation TrustMerck Sharp & Dohme LLCCompleted
-
University College, LondonUniversity of Cambridge; National Institute for Health Research, United Kingdom and other collaboratorsUnknownChronic Obstructive Pulmonary Disease (COPD).United Kingdom
-
Imperial College Healthcare NHS TrustNational Institute for Health Research, United KingdomTerminatedChronic Obstructive Pulmonary DiseasesUnited Kingdom
-
AstraZenecaTerminatedChronic Obstructive Pulmonary Disease With (Acute) ExacerbationUnited Kingdom
-
University of East AngliaUnknownChronic Obstructive Pulmonary Disease | Pulmonary RehabilitationUnited Kingdom
-
Imperial College LondonNational Institute for Health Research, United KingdomCompletedASTHMA | CHRONIC OBSTRUCTIVE PULMONARY DISEASE | HEALTHY SUBJECTSUnited Kingdom
-
Imperial College LondonCompletedChronic Obstructive Pulmonary Disease | Idiopathic Pulmonary FibrosisUnited Kingdom
-
Astellas Pharma Global Development, Inc.CompletedInvasive Aspergillosis | Invasive MucormycosisUnited States, Belgium, Spain
-
National Services for Health Improvement LtdGlaxoSmithKlineCompleted